(RAPT) RAPT Therapeutics - Performance -65.3% in 12m
RAPT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-90.31%
#181 in Peer-Group
Rel. Strength
6.24%
#6952 in Stock-Universe
Total Return 12m
-65.28%
#151 in Peer-Group
Total Return 5y
-96.43%
#152 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 30.00 USD |
| 52 Week Low | 5.98 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 73.80 |
| Buy/Sell Signal +-5 | -2.84 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RAPT (-65.3%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RAPT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RAPT
| Total Return (including Dividends) | RAPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.61% | 2.09% | 4.55% |
| 3 Months | -18.03% | 2.27% | 10.78% |
| 12 Months | -65.28% | -10.84% | 14.71% |
| 5 Years | -96.43% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | RAPT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 17.5% | 18.8% | 79.2% |
| 3 Months | 34.6% | 71.5% | 92.9% |
| 12 Months | -85% | -84.3% | 44.2% |
| 5 Years | -76.8% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th73.00 | 4.43% | 1.97% |
| 3 Month | %th24.50 | -19.85% | -26.01% |
| 12 Month | %th25.00 | -61.06% | -69.73% |
| 5 Years | %th24.00 | -95.17% | -98.32% |
FAQs
Does RAPT Therapeutics (RAPT) outperform the market?
No,
over the last 12 months RAPT made -65.28%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months RAPT made -18.03%, while XBI made 2.27%.
Performance Comparison RAPT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RAPT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.6% | 2.1% | -42.8% | -80% |
| US NASDAQ 100 | QQQ | 3.8% | 1.1% | -44.9% | -80% |
| German DAX 40 | DAX | 4.7% | 6.6% | -55.7% | -95% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.9% | 2.5% | -40.8% | -83% |
| Hongkong Hang Seng | HSI | 5% | 0.8% | -58.5% | -101% |
| India NIFTY 50 | INDA | 5% | 4.5% | -42.5% | -65% |
| Brasil Bovespa | EWZ | 3.2% | -1.2% | -67.3% | -79% |
RAPT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.1% | -0.1% | -49.4% | -94% |
| Consumer Discretionary | XLY | 6.2% | 5% | -34.1% | -85% |
| Consumer Staples | XLP | 8.1% | 8.2% | -41% | -74% |
| Energy | XLE | 9% | 3.1% | -37.3% | -61% |
| Financial | XLF | 4.5% | 3.5% | -45.8% | -94% |
| Health Care | XLV | 5.5% | 4.6% | -35.5% | -60% |
| Industrial | XLI | 5% | 2.9% | -49.4% | -89% |
| Materials | XLB | 6.5% | 5% | -42.1% | -68% |
| Real Estate | XLRE | 9.1% | 6.6% | -40.1% | -78% |
| Technology | XLK | 3.3% | -2.3% | -46% | -77% |
| Utilities | XLU | 7% | 6.6% | -46.1% | -90% |
| Aerospace & Defense | XAR | 2.6% | -3.3% | -64.2% | -118% |
| Biotech | XBI | 6.7% | 4.5% | -28.8% | -54% |
| Homebuilder | XHB | 6.3% | 0.5% | -31.5% | -66% |
| Retail | XRT | 7.7% | 5.2% | -34% | -71% |
RAPT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 11.9% | 1.49% | -33.5% | -55% |
| Natural Gas | UNG | 16.8% | 16% | -27.6% | -57% |
| Gold | GLD | 9.5% | 8.8% | -62.6% | -107% |
| Silver | SLV | 8% | 2.8% | -61.3% | -87% |
| Copper | CPER | 4.3% | 2.4% | -62.5% | -81% |
RAPT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.8% | 3% | -39.6% | -67% |
| iShares High Yield Corp. Bond | HYG | 6.7% | 4.8% | -41.7% | -76% |